AstraZeneca Sweden AB is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory. The company generates revenue through the sale of its innovative medicines and strategic collaborations with other pharmaceutical firms. Founded in 1999 through the merger of Astra AB and Zeneca Group, AstraZeneca has a rich history of pioneering medical advancements and is headquartered in Cambridge, UK, with significant operations in Sweden.